-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Cognitive impairment is a common debilitating symptom of multiple sclerosis (MS), which seriously affects the quality of life of patients.
Prevent vitamin D
In previous studies, researchers have reported that among participants in the clinical trial BENEFIT, those with higher vitamin D levels at 1 or 2 years after recruitment had fewer active lesions and fewer brain atrophy during the 5-year follow-up period.
The study included 278 patients who participated in the clinical trial BENEFIT and completed the 11-year evaluation (BENEFIT-11).
immunity
The results show that higher concentrations of vitamin D are better predictive, while smoking is less effective in predicting cognitive ability.
In summary, the results of this study show that lower vitamin D and smoking after clinical onset can predict the deterioration of long-term cognitive function and neuronal integrity in patients with multiple sclerosis.
Original source:
Marianna Cortese, et al.
Vitamin D, smoking, EBV, and long-term cognitive performance in MS 11-year follow-up of BENEFIT in this message
